Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fomivirsen for the treatment of cytomegalovirus retinitis.

× No keyword cloud information.

21 in total

Review 1. Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.

Authors: B Foxwell; E Andreakos; F Brennan; M Feldmann; C Smith; M Conron
Journal: Ann Rheum Dis Date: 2003-11 Impact factor: 19.103

Review 2. Silencing human genetic diseases with oligonucleotide-based therapies.

Authors: Tamara Martínez; Natalia Wright; Marta López-Fraga; Ana Isabel Jiménez; Covadonga Pañeda
Journal: Hum Genet Date: 2013-03-14 Impact factor: 4.132

3. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.

Authors: Edwin H Yau; Mark C Butler; Jack M Sullivan
Journal: Exp Eye Res Date: 2016-05-25 Impact factor: 3.467

4. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model.

Authors: Leena Pitkänen; Jukka Pelkonen; Marika Ruponen; Seppo Rönkkö; Arto Urtti
Journal: AAPS J Date: 2004-10-07 Impact factor: 4.009

5. Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.

Authors: Jennifer D Oduro; Ralf Uecker; Christian Hagemeier; Lüder Wiebusch
Journal: J Virol Date: 2012-06-20 Impact factor: 5.103

6. Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents.

Authors: Tiffany A Kolniak; Jack M Sullivan
Journal: Exp Eye Res Date: 2011-01-21 Impact factor: 3.467

7. Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.

Authors: Carola Pongratz; Benjamin Yazdanpanah; Hamid Kashkar; Maik J Lehmann; Hans-Georg Kräusslich; Martin Krönke
Journal: PLoS One Date: 2010-10-08 Impact factor: 3.240

Fomivirsen for the treatment of cytomegalovirus retinitis.